A new paradigm in cancer treatment – combining the effectiveness of targeted therapy and immunotherapy

Press Releases

Oxford, UK, 4 October 2015 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of cancer, has announced that it will be giving two poster presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, 5-9 November 2015, Boston, USA.

The poster presentations are as follow:

Abstract B115 - Design and development of a novel series of PI3K-p110beta/delta-selective inhibitors with combined tumor immunotherapeutic, growth inhibition and anti-metastatic activity